1,063 results on '"Lynch, Jane"'
Search Results
2. Trajectories of eGFR and risk of albuminuria in youth with type 2 diabetes: results from the TODAY cohort study
3. Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
4. Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial
5. Practitioners' learning about healthcare supply chain management in the COVID-19 pandemic: a public procurement perspective
6. Policy-led public procurement: does strategic procurement deliver?
7. WCN24-606 PROTEOMIC ANALYSIS UNCOVERS NEW CIRCULATING PROTEINS ASSOCIATED WITH INCIDENT HYPERTENSION OVER 15 YEARS IN YOUTH WITH TYPE 2 DIABETES
8. The Intensive Care Unit Liaison Nurse and their value in averting clinical deterioration: A qualitative descriptive study
9. Effective Supply Chain Collaboration
10. Maximising “Community Benefits” in public procurement: tensions and trade-offs
11. Configuring the strategic orientation of manufacturing firms for economic sustainability : a study of the UK touring caravan industry
12. Serum carotenoids and Pediatric Metabolic Index predict insulin sensitivity in Mexican American children
13. Cardiac Biomarkers in Youth with Type 2 Diabetes Mellitus: Results from the TODAY Study
14. Assessing the Suitability of Supplier Consortia for Public Procurement Contracts
15. Genetics of serum carotenoid concentrations and their correlation with obesity-related traits in Mexican American children
16. LRG1 is an adipokine that mediates obesity-induced hepatosteatosis and insulin resistance
17. Hereditary Malignant Melanoma and the Fammm Syndrome
18. Leveraging social public procurement to deliver public value through community benefits clauses
19. Stress echocardiography in contemporary clinical cardiology: practical considerations and accreditation
20. Epidemiologic Linkage: Diet, Genetics, and Cancer
21. Supplementary Table 2 from Origins and Prevalence of the American Founder Mutation of MSH2
22. Supplementary Figure 1 from Origins and Prevalence of the American Founder Mutation of MSH2
23. Supplementary Table 1 from Origins and Prevalence of the American Founder Mutation of MSH2
24. Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial
25. Lynch Syndrome II in a Navajo Family: A Revisit
26. Congenital Hypothyroidism: Screening and Management
27. P-46 Developing a process to support the wellbeing of children facing the death of a parent
28. Historical Aspects of Lynch Syndrome
29. Prevalence of Suspected Nonalcoholic Fatty Liver Disease in Lean Adolescents in the United States
30. Health records and the law
31. Systems of record keeping
32. Health records used as evidence
33. Health records used to prepare witness statements and reports
34. Sharing information
35. Access to health records by the patient
36. Common errors in the records
37. Assessment criteria for health records
38. Defensive writing
39. Introduction to health records
40. Accountability
41. How do we record?
42. Good practice for health records
43. Health Records in Court
44. Further considerations
45. Will the records stand up to legal scrutiny?
46. The detail
47. What to leave out
48. Who owns the health records?
49. Amending the records
50. Hereditary Factors in Endometrial Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.